Dentsply Sirona Earnings: What To Look For From XRAY

Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting earnings tomorrow after the bell. Here’s what to look for.

Dentsply Sirona beat analysts’ revenue expectations last quarter, reporting revenues of $904 million, down 4.9% year on year. It was a softer quarter for the company, with a significant miss of analysts’ full-year EPS guidance estimates and a significant miss of analysts’ EPS estimates.

Is Dentsply Sirona a buy or sell going into earnings?

This quarter, the market is expecting Dentsply Sirona’s revenue to grow 1.9% year on year, a reversal from the 10.6% decrease it recorded in the same quarter last year.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Dentsply Sirona has missed Wall Street’s revenue estimates multiple times over the last two years.

Looking at Dentsply Sirona’s peers in the dental equipment & technology segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Envista delivered year-on-year revenue growth of 15%, beating analysts’ expectations by 10.6%, and Henry Schein reported revenues up 7.7%, topping estimates by 2.8%. Envista traded up 17.8% following the results.

Investors in the dental equipment & technology segment have had fairly steady hands going into earnings, with share prices down 1.9% on average over the last month. Dentsply Sirona is up 3.3% during the same time and is heading into earnings with an average analyst price target of $13.23 (compared to the current share price of $13.20).

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.